Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | No references |
Homo sapiens | dopamine receptor D3 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | dopamine receptor D3 | 400 aa | 392 aa | 19.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | nephrin | 0.004 | 0.0374 | 0.0455 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0071 | 0.1014 | 0.1254 |
Schistosoma mansoni | vesicular amine transporter | 0.0032 | 0.021 | 0.0256 |
Schistosoma mansoni | thyroid hormone receptor | 0.0084 | 0.1275 | 0.155 |
Brugia malayi | hypothetical protein | 0.0303 | 0.5742 | 0.5734 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0071 | 0.1014 | 0.1254 |
Plasmodium falciparum | glutathione reductase | 0.0031 | 0.0202 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0303 | 0.5742 | 0.5655 |
Echinococcus multilocularis | Immunoglobulin | 0.0032 | 0.021 | 0.0232 |
Echinococcus granulosus | twitchin | 0.004 | 0.0374 | 0.0432 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0032 | 0.021 | 0.0256 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0032 | 0.0211 | 0.0256 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.0584 | 0.0566 |
Echinococcus granulosus | defective proboscis extension response | 0.0032 | 0.021 | 0.0232 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0079 | 0.1175 | 0.1503 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.0584 | 0.0566 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0071 | 0.1014 | 0.1254 |
Mycobacterium tuberculosis | Probable reductase | 0.0071 | 0.1014 | 0.1254 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0031 | 0.0202 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0031 | 0.0202 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0216 | 0.3958 | 0.4797 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0426 | 0.8229 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0031 | 0.0202 | 0.5 |
Schistosoma mansoni | cell adhesion molecule | 0.0042 | 0.042 | 0.051 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0071 | 0.1014 | 0.1254 |
Echinococcus granulosus | Immunoglobulin | 0.0032 | 0.021 | 0.0232 |
Schistosoma mansoni | hypothetical protein | 0.0078 | 0.1148 | 0.1396 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0263 | 0.0062 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0031 | 0.0202 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0584 | 0.0389 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0032 | 0.021 | 0.0191 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Schistosoma mansoni | Protein orai-1 | 0.0303 | 0.5742 | 0.6978 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0079 | 0.1175 | 0.1503 |
Echinococcus granulosus | roundabout 2 | 0.005 | 0.0584 | 0.0687 |
Onchocerca volvulus | 0.0468 | 0.909 | 0.9756 | |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0032 | 0.021 | 0.0191 |
Echinococcus multilocularis | Immunoglobulin | 0.0032 | 0.021 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0211 | 0.0009 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0084 | 0.1275 | 0.1529 |
Schistosoma mansoni | thyroid hormone receptor | 0.0084 | 0.1275 | 0.155 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0079 | 0.1175 | 0.1503 |
Echinococcus multilocularis | neuroglian | 0.004 | 0.0374 | 0.0432 |
Echinococcus multilocularis | tumor protein p63 | 0.0216 | 0.3958 | 0.4797 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0078 | 0.1148 | 0.1375 |
Mycobacterium ulcerans | epoxide hydrolase EphA | 0.0349 | 0.6675 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.042 | 0.0222 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.002 | 0.0024 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0071 | 0.1014 | 0.1254 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0584 | 0.0389 |
Toxoplasma gondii | thioredoxin reductase | 0.0031 | 0.0202 | 0.5 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0032 | 0.021 | 0.0232 |
Plasmodium falciparum | thioredoxin reductase | 0.0031 | 0.0202 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0031 | 0.0202 | 0.0222 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0263 | 0.032 |
Leishmania major | trypanothione reductase | 0.0031 | 0.0202 | 0.5 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0513 | 1 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0031 | 0.0202 | 0.0222 |
Echinococcus granulosus | calcium release activated calcium channel | 0.0303 | 0.5742 | 0.6971 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0584 | 0.039 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0032 | 0.021 | 0.0256 |
Echinococcus multilocularis | calcium release activated calcium channel | 0.0303 | 0.5742 | 0.6971 |
Echinococcus granulosus | neuroglian | 0.004 | 0.0374 | 0.0432 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0263 | 0.0243 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0426 | 0.8229 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0479 | 0.9313 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0079 | 0.1175 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0426 | 0.8229 | 1 |
Echinococcus multilocularis | roundabout 2 | 0.005 | 0.0584 | 0.0687 |
Brugia malayi | glutathione reductase | 0.0031 | 0.0202 | 0.0183 |
Brugia malayi | Thioredoxin reductase | 0.0031 | 0.0202 | 0.0183 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.0584 | 0.039 |
Mycobacterium tuberculosis | Probable epoxide hydrolase EphA (epoxide hydratase) (arene-oxide hydratase) | 0.0349 | 0.6675 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0042 | 0.042 | 0.0487 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0022 | 0.002 | 0.0024 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0078 | 0.1148 | 0.1375 |
Brugia malayi | hypothetical protein | 0.0032 | 0.021 | 0.0191 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0.002 | 0.5 |
Schistosoma mansoni | Protein orai-1 | 0.0303 | 0.5742 | 0.6978 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.021 | 0.0008 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = -7.8 | Ability to displace [125I]-sulpiride from human Dopamine receptor D3, expressed in CHO cells | ChEMBL. | No reference |
Ki (binding) | = -5.8 | Ability to displace [125I]-sulpiride from human Dopamine receptor D2, expressed in CHO cells | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.